Literature DB >> 20944821

Pharmacokinetic interactions with antiepileptic drugs: always the bad actor or simply misunderstood?

Barry E Gidal.   

Abstract

Year:  2010        PMID： 20944821      PMCID： PMC2951690          DOI： 10.1111/j.1535-7511.2010.01374.x

Source DB:  PubMed          Journal:  Epilepsy Curr        ISSN： 1535-7511            Impact factor:   7.500


× No keyword cloud information.
  15 in total

1.  Levetiracetam: preliminary experience in patients with primary brain tumours.

Authors:  G L Wagner; E B Wilms; C A Van Donselaar; Ch J Vecht
Journal:  Seizure       Date:  2003-12       Impact factor: 3.184

Review 2.  The role of membrane transporters in drug delivery to brain tumors.

Authors:  Anne T Nies
Journal:  Cancer Lett       Date:  2007-01-31       Impact factor: 8.679

Review 3.  Drug interactions between chemotherapeutic regimens and antiepileptics.

Authors:  Kevin Yi-Lwern Yap; Wai Keung Chui; Alexandre Chan
Journal:  Clin Ther       Date:  2008-08       Impact factor: 3.393

4.  P450 enzyme inducing and non-enzyme inducing antiepileptics in glioblastoma patients treated with standard chemotherapy.

Authors:  Stefan Oberndorfer; Maria Piribauer; Christine Marosi; Heinz Lahrmann; Peter Hitzenberger; Wolfgang Grisold
Journal:  J Neurooncol       Date:  2005-05       Impact factor: 4.130

Review 5.  Epilepsy in patients with central nervous system tumors.

Authors:  J G Villemure; N de Tribolet
Journal:  Curr Opin Neurol       Date:  1996-12       Impact factor: 5.710

Review 6.  Chemotherapy in adult high-grade glioma: a systematic review and meta-analysis of individual patient data from 12 randomised trials.

Authors:  L A Stewart
Journal:  Lancet       Date:  2002-03-23       Impact factor: 79.321

Review 7.  Interactions between antiepileptic and chemotherapeutic drugs.

Authors:  Charles J Vecht; G Louis Wagner; Erik B Wilms
Journal:  Lancet Neurol       Date:  2003-07       Impact factor: 44.182

8.  Phase I clinical and pharmacokinetic study of irinotecan in adults with recurrent malignant glioma.

Authors:  Mark R Gilbert; Jeffrey G Supko; Tracy Batchelor; Glenn Lesser; Joy D Fisher; Steven Piantadosi; Stuart Grossman
Journal:  Clin Cancer Res       Date:  2003-08-01       Impact factor: 12.531

9.  Correlation of enzyme-inducing anticonvulsant use with outcome of patients with glioblastoma.

Authors:  Kurt A Jaeckle; Karla Ballman; Alfred Furth; Jan C Buckner
Journal:  Neurology       Date:  2009-10-13       Impact factor: 9.910

10.  Retrospective analysis of the efficacy and tolerability of levetiracetam in patients with metastatic brain tumors.

Authors:  Herbert B Newton; Jennifer Dalton; Samuel Goldlust; Dennis Pearl
Journal:  J Neurooncol       Date:  2007-04-13       Impact factor: 4.506
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.